CGB
Click for more information
0.00% 2.1¢ cann global limited

The research is on the use of cannabinoids for treating multiple...

  1. jcurve
    4,067 Posts.
    lightbulb Created with Sketch. 1413
    clock Created with Sketch.
    26/05/19
    20:07
    Post #: 38750881
    The research is on the use of cannabinoids for treating multiple sclerosis and other auto-immune diseases.
    This article reports the MCL funding and gives a surprisingly specific description of Prof. Meiri’s strategy.

    Unique Cannabinoid Profile May Help Control Autoimmune Dysfunction in Multiple Sclerosis
    CGB Price at posting: 3.7¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

SXG Southern Cross finds large gold-antimony zone underneath historic Victorian mine
right-arrow Created with Sketch.
EBR EBR Systems’ heart pacing device on-target to reach the US market
right-arrow Created with Sketch.
RBD Restaurant Brands posts record sales in half year report for FY24
right-arrow Created with Sketch.
TPG ACCC says no issue with TPG Telecom and Optus Mobile sharing regional networks; spectrum
right-arrow Created with Sketch.
PV1 Provaris updates on progress with Uniper under hydrogen MOU – not long after interesting ASX response
right-arrow Created with Sketch.
GBR Great Boulder hits fresh gold finds to the north of Mulga Bill in Meekatharra, WA
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CGB (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.